Medical device licence · 94167 · Class 2
LEUKOSEP SOLX ADDITIVE SET
No longer licensed: discontinued at renewal
Licence status Discontinued at renewal; first licensed December 19, 2014; ended October 31, 2018. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 94167
- Licence holder
- Haemonetics CorporationBoston, Massachusetts, United States
- Risk class
- Class II (low to moderate risk)
- Licence type
- Device Group Family
- First licensed
- December 19, 2014
- Ended
- October 31, 2018
- Devices covered
- 1
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- LEUKOSEP SOLX ADDITIVE SET
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.